Clinical Trial Results:
A Phase II, Randomized, Partially observer-blind, Single-centre study to Evaluate Safety and Immunogenicity of MF59-adjuvanted or Non-adjuvanted H5N1 Booster Influenza Vaccines in Adults Primed with MF59-adjuvanted A/Vietnam/1194/04 (H5N1) vaccine
Summary
|
|
EudraCT number |
2007-005233-11 |
Trial protocol |
GB |
Global completion date |
06 Jul 2011
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
27 Dec 2019
|
First version publication date |
27 Dec 2019
|
Other versions |
|
Summary report(s) |
2007-005233-11 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.